Monocyte-derived dendritic cells from cirrhotic patients retain similar capacity for maturation/activation and antigen presentation as those from healthy subjects
•CD14+ monocytes from cirrhotic patients displayed enhanced M1 and M2 polarization.•MoDC derived from cirrhotic CD14+ monocytes display normal co-stimulation markers.•Antigen-presentation capacity of MoDC from cirrhotic and healthy donors were similar. Few studies have investigated the impact of liv...
Saved in:
Published in | Cellular immunology Vol. 295; no. 1; pp. 36 - 45 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier Inc
01.05.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | •CD14+ monocytes from cirrhotic patients displayed enhanced M1 and M2 polarization.•MoDC derived from cirrhotic CD14+ monocytes display normal co-stimulation markers.•Antigen-presentation capacity of MoDC from cirrhotic and healthy donors were similar.
Few studies have investigated the impact of liver cirrhosis on dendritic cell function. The purpose of this study was to compare the activation and antigen-presentation capacity of monocyte-derived dendritic cells (MoDC) from cirrhotic patients (CIR) relative to healthy donors (HD). MoDC from CIR and HD were matured, phenotyped, irradiated and pulsed with 15mer peptides for two hepatocellular carcinoma-related antigens, alphafetoprotein and glypican-3, then co-cultured with autologous T-cells. Expanded T-cells were evaluated by interferon-gamma ELISPOT and intracellular staining. 15 CIR and 7 HD were studied. While CD14+ monocytes from CIR displayed enhanced M2 polarization, under MoDC-polarizing conditions, we identified no significant difference between HD and CIR in maturation-induced upregulation of co-stimulation markers. Furthermore, no significant differences were observed between CIR and HD in subsequent expansion of tumor antigen-specific IFNγ+ T-cells. Conclusion: MoDCs isolated from cirrhotic individuals retain similar capacity for in vitro activation, maturation and antigen-presentation as those from healthy donors. |
---|---|
AbstractList | Few studies have investigated the impact of liver cirrhosis on dendritic cell function. The purpose of this study was to compare the activation and antigen-presentation capacity of monocyte-derived dendritic cells (MoDC) from cirrhotic patients (CIR) relative to healthy donors (HD). MoDC from CIR and HD were matured, phenotyped, irradiated and pulsed with 15mer peptides for two hepatocellular carcinoma-related antigens, alphafetoprotein and glypican-3, then co-cultured with autologous T-cells. Expanded T-cells were evaluated by interferon-gamma ELISPOT and intracellular staining. 15 CIR and 7 HD were studied. While CD14+ monocytes from CIR displayed enhanced M2 polarization, under MoDC-polarizing conditions, we identified no significant difference between HD and CIR in maturation-induced upregulation of co-stimulation markers. Furthermore, no significant differences were observed between CIR and HD in subsequent expansion of tumor antigen-specific IFNγ+ T-cells.UNLABELLEDFew studies have investigated the impact of liver cirrhosis on dendritic cell function. The purpose of this study was to compare the activation and antigen-presentation capacity of monocyte-derived dendritic cells (MoDC) from cirrhotic patients (CIR) relative to healthy donors (HD). MoDC from CIR and HD were matured, phenotyped, irradiated and pulsed with 15mer peptides for two hepatocellular carcinoma-related antigens, alphafetoprotein and glypican-3, then co-cultured with autologous T-cells. Expanded T-cells were evaluated by interferon-gamma ELISPOT and intracellular staining. 15 CIR and 7 HD were studied. While CD14+ monocytes from CIR displayed enhanced M2 polarization, under MoDC-polarizing conditions, we identified no significant difference between HD and CIR in maturation-induced upregulation of co-stimulation markers. Furthermore, no significant differences were observed between CIR and HD in subsequent expansion of tumor antigen-specific IFNγ+ T-cells.MoDCs isolated from cirrhotic individuals retain similar capacity for in vitro activation, maturation and antigen-presentation as those from healthy donors.CONCLUSIONMoDCs isolated from cirrhotic individuals retain similar capacity for in vitro activation, maturation and antigen-presentation as those from healthy donors. Few studies have investigated the impact of liver cirrhosis on dendritic cell function. The purpose of this study was to compare the activation and antigen-presentation capacity of monocyte-derived dendritic cells (MoDC) from cirrhotic patients (CIR) relative to healthy donors (HD). MoDC from CIR and HD were matured, phenotyped, irradiated and pulsed with 15mer peptides for two hepatocellular carcinoma-related antigens, alphafetoprotein and glypican-3, then co-cultured with autologous T-cells. Expanded T-cells were evaluated by interferon-gamma ELISPOT and intracellular staining. 15 CIR and 7 HD were studied. While CD14+ monocytes from CIR displayed enhanced M2 polarization, under MoDC-polarizing conditions, we identified no significant difference between HD and CIR in maturation-induced upregulation of co-stimulation markers. Furthermore, no significant differences were observed between CIR and HD in subsequent expansion of tumor antigen-specific IFNγ+ T-cells. Few studies have investigated the impact of liver cirrhosis on dendritic cell function. The purpose of this study was to compare the activation and antigen-presentation capacity of monocyte-derived dendritic cells (MoDC) from cirrhotic patients (CIR) relative to healthy donors (HD). MoDC from CIR and HD were matured, phenotyped, irradiated and pulsed with 15mer peptides for two hepatocellular carcinoma-related antigens, alphafetoprotein and glypican-3, then co-cultured with autologous T-cells. Expanded T-cells were evaluated by interferon-gamma ELISPOT and intracellular staining. 15 CIR and 7 HD were studied. While CD14+ monocytes from CIR displayed enhanced M2 polarization, under MoDC-polarizing conditions, we identified no significant difference between HD and CIR in maturation-induced upregulation of co-stimulation markers. Furthermore, no significant differences were observed between CIR and HD in subsequent expansion of tumor antigen-specific IFN gamma + T-cells. Conclusion: MoDCs isolated from cirrhotic individuals retain similar capacity for in vitro activation, maturation and antigen-presentation as those from healthy donors. •CD14+ monocytes from cirrhotic patients displayed enhanced M1 and M2 polarization.•MoDC derived from cirrhotic CD14+ monocytes display normal co-stimulation markers.•Antigen-presentation capacity of MoDC from cirrhotic and healthy donors were similar. Few studies have investigated the impact of liver cirrhosis on dendritic cell function. The purpose of this study was to compare the activation and antigen-presentation capacity of monocyte-derived dendritic cells (MoDC) from cirrhotic patients (CIR) relative to healthy donors (HD). MoDC from CIR and HD were matured, phenotyped, irradiated and pulsed with 15mer peptides for two hepatocellular carcinoma-related antigens, alphafetoprotein and glypican-3, then co-cultured with autologous T-cells. Expanded T-cells were evaluated by interferon-gamma ELISPOT and intracellular staining. 15 CIR and 7 HD were studied. While CD14+ monocytes from CIR displayed enhanced M2 polarization, under MoDC-polarizing conditions, we identified no significant difference between HD and CIR in maturation-induced upregulation of co-stimulation markers. Furthermore, no significant differences were observed between CIR and HD in subsequent expansion of tumor antigen-specific IFNγ+ T-cells. Conclusion: MoDCs isolated from cirrhotic individuals retain similar capacity for in vitro activation, maturation and antigen-presentation as those from healthy donors. Few studies have investigated the impact of liver cirrhosis on dendritic cell function. The purpose of this study was to compare the activation and antigen-presentation capacity of monocyte-derived dendritic cells (MoDC) from cirrhotic patients (CIR) relative to healthy donors (HD). MoDC from CIR and HD were matured, phenotyped, irradiated and pulsed with 15mer peptides for two hepatocellular carcinoma-related antigens, alphafetoprotein and glypican-3, then co-cultured with autologous T-cells. Expanded T-cells were evaluated by interferon-gamma ELISPOT and intracellular staining. 15 CIR and 7 HD were studied. While CD14+ monocytes from CIR displayed enhanced M2 polarization, under MoDC-polarizing conditions, we identified no significant difference between HD and CIR in maturation-induced upregulation of co-stimulation markers. Furthermore, no significant differences were observed between CIR and HD in subsequent expansion of tumor antigen-specific IFNγ+ T-cells. MoDCs isolated from cirrhotic individuals retain similar capacity for in vitro activation, maturation and antigen-presentation as those from healthy donors. |
Author | Li, Yonghai Tanoue, Shiroh Chang, Li-Yuan Kaplan, David E. |
Author_xml | – sequence: 1 givenname: Shiroh surname: Tanoue fullname: Tanoue, Shiroh – sequence: 2 givenname: Li-Yuan surname: Chang fullname: Chang, Li-Yuan – sequence: 3 givenname: Yonghai surname: Li fullname: Li, Yonghai – sequence: 4 givenname: David E. surname: Kaplan fullname: Kaplan, David E. email: dakaplan@mail.med.upenn.edu |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25734547$$D View this record in MEDLINE/PubMed |
BookMark | eNqFUk2P0zAQtdAitrvwE0A-ckl37CROIiQQWvElLeICZ8uxJxtXiR1st1L_Dr8Ud9tFwKUHy9b4zZunN--KXDjvkJCXDNYMmLjZrDVOk53nNQdWr4GvAdonZMWgg4IzUV6QFeRS0TZVd0muYtwAMFZ18Ixc8ropq7pqVuTXV--83icsDAa7Q0MNOhNsspoeBkQ6BD9TbUMY_aG4qGTRpUgDJmUdjXa2kwpUq0Vpm_Z08IHOKm1DBnp3o3Syu4cnVc7kk-w9OroEjJnm9BFpGn3E46wR1ZTGPY3bfoM6xefk6aCmiC9O9zX58fHD99vPxd23T19u398VugZIhdAlM6CrQRuhBigVF6JTfNBCGNEwMCX2PW8gu1dyjag5axlreuhq6M0wlNfk7ZF32fYzGp3lBTXJJdhZhb30ysp_f5wd5b3fyaqC7CXLBK9PBMH_3GJMcrbxYKJy6LdRsqbkLSvbbP5ZqGgq0XZdU2foq79l_dHzuMMMeHME6OBjDDjIvIcHY7NKO0kG8pAYuZGnxMhDYiRwmeORu-v_uh8HnOt7d-zDvJKdxSCjzsHQaGzIW5PG2zMMvwHZtuQG |
CitedBy_id | crossref_primary_10_1002_hep_28419 crossref_primary_10_1016_j_jhep_2020_03_027 crossref_primary_10_1038_s41575_021_00520_7 crossref_primary_10_1080_1061186X_2024_2347365 |
Cites_doi | 10.1158/1078-0432.CCR-04-0502 10.1016/j.jim.2005.05.010 10.1016/j.smim.2009.05.010 10.4049/jimmunol.160.3.1139 10.1186/1471-2407-7-119 10.4049/jimmunol.1201271 10.1038/mt.2008.77 10.1016/j.jhep.2004.09.014 10.4049/jimmunol.179.7.4307 10.1002/hep.22626 10.4049/jimmunol.1201008 10.1111/j.1365-2893.2007.00934.x 10.4049/jimmunol.162.9.5584 10.1128/JVI.02080-07 10.1016/S1470-2045(01)00486-7 10.1111/j.1365-2249.2010.04246.x 10.4161/hv.22473 10.1111/j.1349-7006.2004.tb03248.x 10.4049/jimmunol.179.6.3515 10.1146/annurev.immunol.23.021704.115839 10.3748/wjg.v17.i48.5260 10.1002/ijc.28372 10.1016/S0168-8278(99)80231-1 10.1093/intimm/dxp077 10.1155/2011/249281 10.1089/vim.2014.0056 10.4049/jimmunol.0900187 10.1182/blood.V97.10.3171 10.1002/hep.21176 10.1371/journal.pone.0055264 10.4049/jimmunol.170.8.4069 10.1007/s00262-007-0337-9 10.1182/blood-2003-04-1339 10.1053/gast.2001.21212 10.1016/j.imbio.2014.07.020 10.1007/s00262-002-0360-9 10.1016/j.jim.2005.11.023 10.1111/j.1530-0277.2003.tb04431.x 10.1016/j.cellimm.2009.09.003 10.1097/01.ALC.0000127104.80398.9B 10.1016/j.yexmp.2014.04.003 10.1128/JVI.77.20.10862-10871.2003 10.1111/liv.12284 10.4049/jimmunol.179.10.7137 10.1159/000341697 10.1016/j.clim.2011.02.014 10.3892/ijo.2012.1626 10.1038/nature10673 10.1111/j.1742-1241.2011.02814.x 10.1158/1078-0432.CCR-05-2856 10.1053/j.gastro.2013.10.031 |
ContentType | Journal Article |
Copyright | 2015 Published by Elsevier Inc. 2015 Published by Elsevier Inc. 2015 |
Copyright_xml | – notice: 2015 – notice: Published by Elsevier Inc. – notice: 2015 Published by Elsevier Inc. 2015 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7T5 H94 5PM |
DOI | 10.1016/j.cellimm.2015.02.008 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Immunology Abstracts AIDS and Cancer Research Abstracts PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AIDS and Cancer Research Abstracts Immunology Abstracts |
DatabaseTitleList | MEDLINE - Academic AIDS and Cancer Research Abstracts MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1090-2163 |
EndPage | 45 |
ExternalDocumentID | PMC4405471 25734547 10_1016_j_cellimm_2015_02_008 S0008874915000428 |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: Pennsylvania Commonwealth Universal Research Endowment – fundername: NIH grantid: R01 CA166111 funderid: http://dx.doi.org/10.13039/100000002 – fundername: CSRD VA grantid: I01 CX000981 – fundername: NIDDK NIH HHS grantid: P30 DK050306 – fundername: NCI NIH HHS grantid: R01 CA166111 |
GroupedDBID | --- --K --M -~X .55 .GJ .~1 0R~ 1B1 1KJ 1RT 1~. 1~5 29B 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 6J9 7-5 71M 8P~ 9JM AAAJQ AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AARKO AAXUO ABFRF ABGSF ABJNI ABMAC ABUDA ABXDB ACDAQ ACGFO ACGFS ACNCT ACRLP ADBBV ADEZE ADFGL ADMUD ADUVX AEBSH AEFWE AEHWI AEKER AENEX AFKWA AFTJW AFXIZ AGEKW AGHFR AGRDE AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJOXV AKRWK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC CAG CJTIS COF CS3 DM4 DU5 EBS EFBJH EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HLW HMG HVGLF HX~ HZ~ IHE J1W J5H K-O KOM L7B LG5 LUGTX LX2 LZ5 M41 MO0 N9A O-L O9- OAUVE OHT OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SBG SDF SDG SDP SES SEW SIN SPCBC SSI SSU SSZ T5K UNMZH WH7 WUQ X7M XOL XPP Y6R YYP ZGI ZMT ~G- AATTM AAXKI AAYWO AAYXX ABWVN ACRPL ACVFH ADCNI ADNMO AEIPS AEUPX AFJKZ AFPUW AGCQF AGQPQ AGRNS AIGII AIIUN AKBMS AKYEP ANKPU APXCP BNPGV CITATION SSH CGR CUY CVF ECM EFKBS EIF NPM 7X8 7T5 H94 5PM |
ID | FETCH-LOGICAL-c500t-6c31d0c4fcd6af03a2669a2fc66d6710d3ebb27010132ceec218117b0950bdff3 |
IEDL.DBID | .~1 |
ISSN | 0008-8749 1090-2163 |
IngestDate | Thu Aug 21 13:52:18 EDT 2025 Fri Jul 11 03:37:49 EDT 2025 Fri Jul 11 00:01:57 EDT 2025 Mon Jul 21 05:58:21 EDT 2025 Thu Apr 24 23:12:46 EDT 2025 Tue Jul 01 01:48:07 EDT 2025 Tue Jul 23 07:56:02 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Human Dendritic cell Monocyte MoDC M1 macrophage HCC AFP CIR PBMC Cirrhosis M2 macrophage GPC3 HCV Glypican-3 HD Hepatitis C |
Language | English |
License | Published by Elsevier Inc. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c500t-6c31d0c4fcd6af03a2669a2fc66d6710d3ebb27010132ceec218117b0950bdff3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | http://doi.org/10.1016/j.cellimm.2015.02.008 |
PMID | 25734547 |
PQID | 1674689975 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4405471 proquest_miscellaneous_1732813857 proquest_miscellaneous_1674689975 pubmed_primary_25734547 crossref_citationtrail_10_1016_j_cellimm_2015_02_008 crossref_primary_10_1016_j_cellimm_2015_02_008 elsevier_sciencedirect_doi_10_1016_j_cellimm_2015_02_008 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2015-05-01 |
PublicationDateYYYYMMDD | 2015-05-01 |
PublicationDate_xml | – month: 05 year: 2015 text: 2015-05-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | Cellular immunology |
PublicationTitleAlternate | Cell Immunol |
PublicationYear | 2015 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Bain, Fatmi, Zoulim, Zarski, Trepo, Inchauspe (b0165) 2001; 120 Sangiovanni, Prati, Fasani, Ronchi, Romeo, Manini, Del Ninno, Morabito, Colombo (b0010) 2006; 43 Y. Xu, H. Li, R. L. Gao, O. Adeyemo, M. Itkin and D. E. Kaplan, Expansion of interferon-gamma-producing multifunctional CD4+ T-cells and dysfunctional CD8+ T-cells by glypican-3 peptide library in hepatocellular carcinoma patients, Clin Immunol. In press (2011). Van Gulck, Vanham, Heyndrickx, Coppens, Vereecken, Atkinson, Florence, Kint, Berneman, Van Tendeloo (b0220) 2008; 82 Pen, De Keersmaecker, Maenhout, Van Nuffel, Heirman, Corthals, Escors, Bonehill, Thielemans, Breckpot, Aerts (b0245) 2013; 191 Butterfield, Ribas, Potter, Economou (b0045) 2007; 56 Zhong, Ma, Wu, Zhao, Yuan, Wu, Zhang, Huang, You, Li (b0060) 2012; 66 Kakazu, Kanno, Ueno, Shimosegawa (b0215) 2007; 179 Kayashima, Toshima, Okano, Taketomi, Harada, Yamashita, Tomita, Shirabe, Maehara (b0230) 2010; 185 Szabo, Catalano, White, Mandrekar (b0200) 2004; 28 Butterfield, Ribas, Dissette, Lee, Yang, De la Rocha, Duran, Hernandez, Seja, Potter, McBride, Finn, Glaspy, Economou (b0015) 2006; 12 Jenkins, Perona-Wright, Worsley, Ishii, MacDonald (b0115) 2007; 179 Iwashita, Tahara, Goto, Sasaki, Kai, Seike, Chen, Kawano, Kitano (b0025) 2003; 52 Sun, Fink (b0130) 2007; 179 Mellman, Coukos, Dranoff (b0035) 2011; 480 Dauer, Schad, Herten, Junkmann, Bauer, Kiefl, Endres, Eigler (b0105) 2005; 302 Ma, Clark (b0135) 2009; 21 Ho, Nguyen, Wolfl, Kuball, Greenberg (b0205) 2006; 310 Jarnjak-Jankovic, Hammerstad, Saeboe-Larssen, Kvalheim, Gaudernack (b0210) 2007; 7 Agrawal, Samrat, Agrawal, Tyrrell, Kumar (b0195) 2014 Nakamoto, Mizukoshi, Kitahara, Arihara, Sakai, Kakinoki, Fujita, Marukawa, Arai, Yamashita, Mukaida, Matsushima, Matsui, Kaneko (b0070) 2011; 163 Schmidt, Neumann-Haefelin, Thimme (b0090) 2012; 30 Kvistborg, Boegh, Pedersen, Claesson, Zocca (b0095) 2009; 260 A. Vogt, E. Sievers, V. Lukacs-Kornek, G. Decker, E. Raskopf, N. Meumann, H. Buning, T. Sauerbruch, C.P. Strassburg, I.G. Schmidt-Wolf and M.A. Gonzalez-Carmona, Improving immunotherapy of hepatocellular carcinoma (HCC) using dendritic cells (DC) engineered to express IL-12 in vivo, Liver Int. (2013). Nobuoka, Yoshikawa, Sawada, Fujiwara, Nakatsura (b0055) 2013; 9 Barnes, Salio, Cerundolo, Francesco, Pardoll, Klenerman, Cox (b0185) 2008; 15 Shang, Chen, Zhang, Pang, Qiao, Peng, Qin, Fei, Mei, Leng, Gnjatic, Ritter, Simpson, Old, Chen (b0040) 2004; 10 Bray, Vujanovic, Butterfield (b0145) 2011; 2011 Szabo, Gogolak, Pazmandi, Kis-Toth, Riedl, Wizel, Lingnau, Bacsi, Rethi, Rajnavolgyi (b0240) 2013; 8 Ju, Ju, Ge, Qiu, Lu, Qiu, Fu, Liu, Wang, Hu, Shu, Zhang (b0120) 2009; 21 Watts (b0125) 2005; 23 Dolganiuc, Kodys, Kopasz, Marshall, Mandrekar, Szabo (b0170) 2003; 27 Bonehill, Tuyaerts, Van Nuffel, Heirman, Bos, Fostier, Neyns, Thielemans (b0250) 2008; 16 Wijesundera, Izawa, Tennakoon, Murakami, Golbar, Katou-Ichikawa, Tanaka, Kuwamura, Yamate (b0260) 2014; 96 Parkin (b0005) 2001; 2 Piccioli, Tavarini, Nuti, Colombatto, Brunetto, Bonino, Ciccorossi, Zorat, Pozzato, Comar, Abrignani, Wack (b0180) 2005; 42 Kanto, Hayashi, Takehara, Tatsumi, Kuzushita, Ito, Sasaki, Kasahara, Hori (b0160) 1999; 162 Qiu, Xu, Yun, Wang, Zhang, Meng, Ou-Yang, Yun (b0065) 2011; 17 Dauer, Obermaier, Herten, Haerle, Pohl, Rothenfusser, Schnurr, Endres, Eigler (b0100) 2003; 170 Auffermann-Gretzinger, Keeffe, Levy (b0150) 2001; 97 Bak, Barnkob, Bai, Higham, Wittrup, Chen (b0110) 2012; 189 Tada, Abe, Hirooka, Ikeda, Hiasa, Lee, Jung, Lee, Lee, Bae, Onji (b0020) 2012; 41 Sarobe, Lasarte, Zabaleta, Arribillaga, Arina, Melero, Borras-Cuesta, Prieto (b0155) 2003; 77 Cui, Wang, Zhao, Jin, Wang, Niu, Terunuma, He, Li (b0050) 2014; 134 Ninomiya, Akbar, Masumoto, Horiike, Onji (b0080) 1999; 31 Ikeda, Chamoto, Tsuji, Suzuki, Wakita, Takeshima, Nishimura (b0030) 2004; 95 Goode, Warburton, Gelson, Watson (b0255) 2013; 145 Hatipoglu, Ercan, Acilan, Basalp, Durali, Baykal (b0190) 2014 Palmer, Midgley, Mirza, Torr, Ahmed, Steele, Steven, Kerr, Young, Adams (b0075) 2009; 49 Sun, Wang, Zhang (b0140) 2006; 3 Tuting, Wilson, Martin, Kasamon, Rowles, Ma, Slingluff, Wagner, van der Bruggen, Baar, Lotze, Storkus (b0235) 1998; 160 Longman, Talal, Jacobson, Albert, Rice (b0175) 2004; 103 Cui (10.1016/j.cellimm.2015.02.008_b0050) 2014; 134 Dolganiuc (10.1016/j.cellimm.2015.02.008_b0170) 2003; 27 Goode (10.1016/j.cellimm.2015.02.008_b0255) 2013; 145 Watts (10.1016/j.cellimm.2015.02.008_b0125) 2005; 23 Barnes (10.1016/j.cellimm.2015.02.008_b0185) 2008; 15 Tuting (10.1016/j.cellimm.2015.02.008_b0235) 1998; 160 Jarnjak-Jankovic (10.1016/j.cellimm.2015.02.008_b0210) 2007; 7 Ma (10.1016/j.cellimm.2015.02.008_b0135) 2009; 21 Dauer (10.1016/j.cellimm.2015.02.008_b0100) 2003; 170 Mellman (10.1016/j.cellimm.2015.02.008_b0035) 2011; 480 Sarobe (10.1016/j.cellimm.2015.02.008_b0155) 2003; 77 Zhong (10.1016/j.cellimm.2015.02.008_b0060) 2012; 66 Longman (10.1016/j.cellimm.2015.02.008_b0175) 2004; 103 10.1016/j.cellimm.2015.02.008_b0085 Sun (10.1016/j.cellimm.2015.02.008_b0130) 2007; 179 Dauer (10.1016/j.cellimm.2015.02.008_b0105) 2005; 302 Nakamoto (10.1016/j.cellimm.2015.02.008_b0070) 2011; 163 Auffermann-Gretzinger (10.1016/j.cellimm.2015.02.008_b0150) 2001; 97 Bonehill (10.1016/j.cellimm.2015.02.008_b0250) 2008; 16 Iwashita (10.1016/j.cellimm.2015.02.008_b0025) 2003; 52 Pen (10.1016/j.cellimm.2015.02.008_b0245) 2013; 191 Nobuoka (10.1016/j.cellimm.2015.02.008_b0055) 2013; 9 Van Gulck (10.1016/j.cellimm.2015.02.008_b0220) 2008; 82 Ninomiya (10.1016/j.cellimm.2015.02.008_b0080) 1999; 31 Schmidt (10.1016/j.cellimm.2015.02.008_b0090) 2012; 30 Palmer (10.1016/j.cellimm.2015.02.008_b0075) 2009; 49 Sangiovanni (10.1016/j.cellimm.2015.02.008_b0010) 2006; 43 Butterfield (10.1016/j.cellimm.2015.02.008_b0015) 2006; 12 Kvistborg (10.1016/j.cellimm.2015.02.008_b0095) 2009; 260 Agrawal (10.1016/j.cellimm.2015.02.008_b0195) 2014 Wijesundera (10.1016/j.cellimm.2015.02.008_b0260) 2014; 96 Ikeda (10.1016/j.cellimm.2015.02.008_b0030) 2004; 95 Sun (10.1016/j.cellimm.2015.02.008_b0140) 2006; 3 Ho (10.1016/j.cellimm.2015.02.008_b0205) 2006; 310 Piccioli (10.1016/j.cellimm.2015.02.008_b0180) 2005; 42 Bray (10.1016/j.cellimm.2015.02.008_b0145) 2011; 2011 Parkin (10.1016/j.cellimm.2015.02.008_b0005) 2001; 2 Bain (10.1016/j.cellimm.2015.02.008_b0165) 2001; 120 Kayashima (10.1016/j.cellimm.2015.02.008_b0230) 2010; 185 Shang (10.1016/j.cellimm.2015.02.008_b0040) 2004; 10 Bak (10.1016/j.cellimm.2015.02.008_b0110) 2012; 189 Butterfield (10.1016/j.cellimm.2015.02.008_b0045) 2007; 56 Szabo (10.1016/j.cellimm.2015.02.008_b0200) 2004; 28 10.1016/j.cellimm.2015.02.008_b0225 Kanto (10.1016/j.cellimm.2015.02.008_b0160) 1999; 162 Kakazu (10.1016/j.cellimm.2015.02.008_b0215) 2007; 179 Jenkins (10.1016/j.cellimm.2015.02.008_b0115) 2007; 179 Hatipoglu (10.1016/j.cellimm.2015.02.008_b0190) 2014 Tada (10.1016/j.cellimm.2015.02.008_b0020) 2012; 41 Qiu (10.1016/j.cellimm.2015.02.008_b0065) 2011; 17 Ju (10.1016/j.cellimm.2015.02.008_b0120) 2009; 21 Szabo (10.1016/j.cellimm.2015.02.008_b0240) 2013; 8 22971679 - Int J Oncol. 2012 Nov;41(5):1601-9 22171902 - Int J Clin Pract. 2012 Jan;66(1):21-7 17785785 - J Immunol. 2007 Sep 15;179(6):3515-23 25148301 - Viral Immunol. 2014 Oct;27(8):412-7 18980227 - Hepatology. 2009 Jan;49(1):124-32 22193102 - Nature. 2011 Dec 22;480(7378):480-9 15629508 - J Hepatol. 2005 Jan;42(1):61-7 14512536 - J Virol. 2003 Oct;77(20):10862-71 22798683 - J Immunol. 2012 Aug 15;189(4):1708-16 22219594 - World J Gastroenterol. 2011 Dec 28;17(48):5260-6 19818956 - Cell Immunol. 2009;260(1):56-62 19524453 - Semin Immunol. 2009 Oct;21(5):265-72 15471553 - Cancer Sci. 2004 Sep;95(9):697-703 23405128 - PLoS One. 2013;8(2):e55264 24409494 - Gastroenterology. 2013 Dec;145(6):1481-4 16675576 - Clin Cancer Res. 2006 May 1;12(9):2817-25 15771565 - Annu Rev Immunol. 2005;23:23-68 16469329 - J Immunol Methods. 2006 Mar 20;310(1-2):40-52 20498356 - J Immunol. 2010 Jul 1;185(1):698-708 12682236 - J Immunol. 2003 Apr 15;170(8):4069-76 19684160 - Int Immunol. 2009 Oct;21(10):1135-44 17982106 - J Immunol. 2007 Nov 15;179(10):7137-46 18194173 - J Viral Hepat. 2008 Mar;15(3):219-28 16893500 - Cell Mol Immunol. 2006 Jun;3(3):197-203 18431362 - Mol Ther. 2008 Jun;16(6):1170-80 15501973 - Clin Cancer Res. 2004 Oct 15;10(20):6946-55 25150150 - Immunobiology. 2014 Dec;219(12):944-9 23442593 - Hum Vaccin Immunother. 2013 Jan;9(1):210-2 24747241 - Exp Mol Pathol. 2014 Jun;96(3):382-92 15992809 - J Immunol Methods. 2005 Jul;302(1-2):145-55 10228041 - J Immunol. 1999 May 1;162(9):5584-91 23842750 - J Immunol. 2013 Aug 15;191(4):1976-83 11905707 - Lancet Oncol. 2001 Sep;2(9):533-43 18234800 - J Virol. 2008 Apr;82(7):3561-73 23825037 - Int J Cancer. 2014 Jan 15;134(2):342-51 17522860 - Cancer Immunol Immunother. 2007 Dec;56(12):1931-43 17608923 - BMC Cancer. 2007;7:119 21087443 - Clin Exp Immunol. 2011 Feb;163(2):165-77 23108304 - Dig Dis. 2012;30(5):483-91 10453947 - J Hepatol. 1999 Aug;31(2):323-31 16729298 - Hepatology. 2006 Jun;43(6):1303-10 15166660 - Alcohol Clin Exp Res. 2004 May;28(5):824-8 9570527 - J Immunol. 1998 Feb 1;160(3):1139-47 23998316 - Liver Int. 2014 Mar;34(3):447-61 21969837 - Clin Dev Immunol. 2011;2011:249281 12824825 - Alcohol Clin Exp Res. 2003 Jun;27(6):1023-31 11159892 - Gastroenterology. 2001 Feb;120(2):512-24 14525790 - Blood. 2004 Feb 1;103(3):1026-9 17878324 - J Immunol. 2007 Oct 1;179(7):4307-12 11342445 - Blood. 2001 May 15;97(10):3171-6 12649744 - Cancer Immunol Immunother. 2003 Mar;52(3):155-61 21419713 - Clin Immunol. 2011 Jun;139(3):302-13 |
References_xml | – volume: 191 start-page: 1976 year: 2013 end-page: 1983 ident: b0245 article-title: Modulation of regulatory T cell function by monocyte-derived dendritic cells matured through electroporation with mRNA encoding CD40 ligand, constitutively active TLR4, and CD70 publication-title: J. Immunol. – volume: 97 start-page: 3171 year: 2001 end-page: 3176 ident: b0150 article-title: Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection publication-title: Blood – volume: 2011 start-page: 249281 year: 2011 ident: b0145 article-title: Dendritic cell-based vaccines positively impact natural killer and regulatory T cells in hepatocellular carcinoma patients publication-title: Clin. Dev. Immunol. – volume: 179 start-page: 7137 year: 2007 end-page: 7146 ident: b0215 article-title: Extracellular branched-chain amino acids, especially valine, regulate maturation and function of monocyte-derived dendritic cells publication-title: J. Immunol. – reference: Y. Xu, H. Li, R. L. Gao, O. Adeyemo, M. Itkin and D. E. Kaplan, Expansion of interferon-gamma-producing multifunctional CD4+ T-cells and dysfunctional CD8+ T-cells by glypican-3 peptide library in hepatocellular carcinoma patients, Clin Immunol. In press (2011). – volume: 27 start-page: 1023 year: 2003 end-page: 1031 ident: b0170 article-title: Additive inhibition of dendritic cell allostimulatory capacity by alcohol and hepatitis C is not restored by DC maturation and involves abnormal IL-10 and IL-2 induction publication-title: Alcohol. Clin. Exp. Res. – volume: 2 start-page: 533 year: 2001 end-page: 543 ident: b0005 article-title: Global cancer statistics in the year 2000 publication-title: Lancet Oncol. – volume: 179 start-page: 4307 year: 2007 end-page: 4312 ident: b0130 article-title: A new class of reverse signaling costimulators belongs to the TNF family publication-title: J. Immunol. – volume: 16 start-page: 1170 year: 2008 end-page: 1180 ident: b0250 article-title: Enhancing the T-cell stimulatory capacity of human dendritic cells by co-electroporation with CD40L, CD70 and constitutively active TLR4 encoding mRNA publication-title: Mol. Ther. – volume: 163 start-page: 165 year: 2011 end-page: 177 ident: b0070 article-title: Prolonged recurrence-free survival following OK432-stimulated dendritic cell transfer into hepatocellular carcinoma during transarterial embolization publication-title: Clin. Exp. Immunol. – volume: 77 start-page: 10862 year: 2003 end-page: 10871 ident: b0155 article-title: Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responses publication-title: J. Virol. – volume: 21 start-page: 265 year: 2009 end-page: 272 ident: b0135 article-title: The role of CD40 and CD154/CD40L in dendritic cells publication-title: Semin. Immunol. – volume: 12 start-page: 2817 year: 2006 end-page: 2825 ident: b0015 article-title: A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptides publication-title: Clin. Cancer Res. – volume: 95 start-page: 697 year: 2004 end-page: 703 ident: b0030 article-title: The critical role of type-1 innate and acquired immunity in tumor immunotherapy publication-title: Cancer Sci. – volume: 3 start-page: 197 year: 2006 end-page: 203 ident: b0140 article-title: Dendritic cell as therapeutic vaccines against tumors and its role in therapy for hepatocellular carcinoma publication-title: Cell. Mol. Immunol. – volume: 49 start-page: 124 year: 2009 end-page: 132 ident: b0075 article-title: A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma publication-title: Hepatology – volume: 145 start-page: 1481 year: 2013 end-page: 1484 ident: b0255 article-title: Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function publication-title: Gastroenterology – volume: 28 start-page: 824 year: 2004 end-page: 828 ident: b0200 article-title: Acute alcohol consumption inhibits accessory cell function of monocytes and dendritic cells publication-title: Alcohol. Clin. Exp. Res. – volume: 96 start-page: 382 year: 2014 end-page: 392 ident: b0260 article-title: M1- and M2-macrophage polarization in rat liver cirrhosis induced by thioacetamide (TAA), focusing on Iba1 and galectin-3 publication-title: Exp. Mol. Pathol. – volume: 23 start-page: 23 year: 2005 end-page: 68 ident: b0125 article-title: TNF/TNFR family members in costimulation of T cell responses publication-title: Annu. Rev. Immunol. – year: 2014 ident: b0190 article-title: Hepatitis B virus e antigen (HBeAg) may have a negative effect on dendritic cell generation publication-title: Immunobiology – volume: 52 start-page: 155 year: 2003 end-page: 161 ident: b0025 article-title: A phase I study of autologous dendritic cell-based immunotherapy for patients with unresectable primary liver cancer publication-title: Cancer Immunol. Immunother. – volume: 41 start-page: 1601 year: 2012 end-page: 1609 ident: b0020 article-title: Phase I/II study of immunotherapy using tumor antigen-pulsed dendritic cells in patients with hepatocellular carcinoma publication-title: Int. J. Oncol. – volume: 82 start-page: 3561 year: 2008 end-page: 3573 ident: b0220 article-title: Efficient in vitro expansion of human immunodeficiency virus (HIV)-specific T-cell responses by gag mRNA-electroporated dendritic cells from treated and untreated HIV type 1-infected individuals publication-title: J. Virol. – reference: A. Vogt, E. Sievers, V. Lukacs-Kornek, G. Decker, E. Raskopf, N. Meumann, H. Buning, T. Sauerbruch, C.P. Strassburg, I.G. Schmidt-Wolf and M.A. Gonzalez-Carmona, Improving immunotherapy of hepatocellular carcinoma (HCC) using dendritic cells (DC) engineered to express IL-12 in vivo, Liver Int. (2013). – volume: 134 start-page: 342 year: 2014 end-page: 351 ident: b0050 article-title: Combination of radiofrequency ablation and sequential cellular immunotherapy improves progression-free survival for patients with hepatocellular carcinoma publication-title: Int. J. Cancer – volume: 103 start-page: 1026 year: 2004 end-page: 1029 ident: b0175 article-title: Presence of functional dendritic cells in patients chronically infected with hepatitis C virus publication-title: Blood – volume: 17 start-page: 5260 year: 2011 end-page: 5266 ident: b0065 article-title: Hepatocellular carcinoma-specific immunotherapy with synthesized alpha1,3-galactosyl epitope-pulsed dendritic cells and cytokine-induced killer cells publication-title: World J. Gastroenterol. – volume: 10 start-page: 6946 year: 2004 end-page: 6955 ident: b0040 article-title: The spontaneous CD8+ T-cell response to HLA-A2-restricted NY-ESO-1b peptide in hepatocellular carcinoma patients publication-title: Clin. Cancer Res. – volume: 260 start-page: 56 year: 2009 end-page: 62 ident: b0095 article-title: Fast generation of dendritic cells publication-title: Cell. Immunol. – volume: 21 start-page: 1135 year: 2009 end-page: 1144 ident: b0120 article-title: A novel approach to induce human DCs from monocytes by triggering 4–1BBL reverse signaling publication-title: Int. Immunol. – volume: 15 start-page: 219 year: 2008 end-page: 228 ident: b0185 article-title: Monocyte derived dendritic cells retain their functional capacity in patients following infection with hepatitis C virus publication-title: J. Viral Hepatol. – volume: 8 start-page: e55264 year: 2013 ident: b0240 article-title: The two-component adjuvant IC31(R) boosts type i interferon production of human monocyte-derived dendritic cells via ligation of endosomal TLRs publication-title: PLoS ONE – volume: 480 start-page: 480 year: 2011 end-page: 489 ident: b0035 article-title: Cancer immunotherapy comes of age publication-title: Nature – volume: 179 start-page: 3515 year: 2007 end-page: 3523 ident: b0115 article-title: Dendritic cell expression of OX40 ligand acts as a costimulatory, not polarizing, signal for optimal Th2 priming and memory induction in vivo publication-title: J. Immunol. – volume: 160 start-page: 1139 year: 1998 end-page: 1147 ident: b0235 article-title: Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-alpha publication-title: J. Immunol. – volume: 66 start-page: 21 year: 2012 end-page: 27 ident: b0060 article-title: Adoptive immunotherapy for postoperative hepatocellular carcinoma: a systematic review publication-title: Int. J. Clin. Pract. – volume: 185 start-page: 698 year: 2010 end-page: 708 ident: b0230 article-title: Intratumoral neoadjuvant immunotherapy using IL-12 and dendritic cells is an effective strategy to control recurrence of murine hepatocellular carcinoma in immunosuppressed mice publication-title: J. Immunol. – volume: 9 start-page: 210 year: 2013 end-page: 212 ident: b0055 article-title: Peptide vaccines for hepatocellular carcinoma publication-title: Hum. vaccines immunother. – volume: 310 start-page: 40 year: 2006 end-page: 52 ident: b0205 article-title: In vitro methods for generating CD8+ T-cell clones for immunotherapy from the naive repertoire publication-title: J. Immunol. Methods – year: 2014 ident: b0195 article-title: Co-incubation with core proteins of HBV and HCV leads to modulation of human dendritic cells publication-title: Viral Immunol. – volume: 30 start-page: 483 year: 2012 end-page: 491 ident: b0090 article-title: Cellular immune responses to hepatocellular carcinoma: lessons for immunotherapy publication-title: Dig. Dis. – volume: 43 start-page: 1303 year: 2006 end-page: 1310 ident: b0010 article-title: The natural history of compensated cirrhosis due to hepatitis C virus: a 17-year cohort study of 214 patients publication-title: Hepatology – volume: 7 start-page: 119 year: 2007 ident: b0210 article-title: A full scale comparative study of methods for generation of functional dendritic cells for use as cancer vaccines publication-title: BMC Cancer – volume: 56 start-page: 1931 year: 2007 end-page: 1943 ident: b0045 article-title: Spontaneous and vaccine induced AFP-specific T cell phenotypes in subjects with AFP-positive hepatocellular cancer publication-title: Cancer Immunol. Immunother. – volume: 31 start-page: 323 year: 1999 end-page: 331 ident: b0080 article-title: Dendritic cells with immature phenotype and defective function in the peripheral blood from patients with hepatocellular carcinoma publication-title: J. Hepatol. – volume: 170 start-page: 4069 year: 2003 end-page: 4076 ident: b0100 article-title: Mature dendritic cells derived from human monocytes within 48 hours: a novel strategy for dendritic cell differentiation from blood precursors publication-title: J. Immunol. – volume: 120 start-page: 512 year: 2001 end-page: 524 ident: b0165 article-title: Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection publication-title: Gastroenterology – volume: 302 start-page: 145 year: 2005 end-page: 155 ident: b0105 article-title: FastDC derived from human monocytes within 48 h effectively prime tumor antigen-specific cytotoxic T cells publication-title: J. Immunol. Methods – volume: 42 start-page: 61 year: 2005 end-page: 67 ident: b0180 article-title: Comparable functions of plasmacytoid and monocyte-derived dendritic cells in chronic hepatitis C patients and healthy donors publication-title: J. Hepatol. – volume: 189 start-page: 1708 year: 2012 end-page: 1716 ident: b0110 article-title: Differential requirement for CD70 and CD80/CD86 in dendritic cell-mediated activation of tumor-tolerized CD8 T cells publication-title: J. Immunol. – volume: 162 start-page: 5584 year: 1999 end-page: 5591 ident: b0160 article-title: Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals publication-title: J. Immunol. – volume: 10 start-page: 6946 year: 2004 ident: 10.1016/j.cellimm.2015.02.008_b0040 article-title: The spontaneous CD8+ T-cell response to HLA-A2-restricted NY-ESO-1b peptide in hepatocellular carcinoma patients publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-04-0502 – volume: 302 start-page: 145 year: 2005 ident: 10.1016/j.cellimm.2015.02.008_b0105 article-title: FastDC derived from human monocytes within 48 h effectively prime tumor antigen-specific cytotoxic T cells publication-title: J. Immunol. Methods doi: 10.1016/j.jim.2005.05.010 – volume: 21 start-page: 265 year: 2009 ident: 10.1016/j.cellimm.2015.02.008_b0135 article-title: The role of CD40 and CD154/CD40L in dendritic cells publication-title: Semin. Immunol. doi: 10.1016/j.smim.2009.05.010 – volume: 160 start-page: 1139 year: 1998 ident: 10.1016/j.cellimm.2015.02.008_b0235 article-title: Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-alpha publication-title: J. Immunol. doi: 10.4049/jimmunol.160.3.1139 – volume: 7 start-page: 119 year: 2007 ident: 10.1016/j.cellimm.2015.02.008_b0210 article-title: A full scale comparative study of methods for generation of functional dendritic cells for use as cancer vaccines publication-title: BMC Cancer doi: 10.1186/1471-2407-7-119 – volume: 189 start-page: 1708 year: 2012 ident: 10.1016/j.cellimm.2015.02.008_b0110 article-title: Differential requirement for CD70 and CD80/CD86 in dendritic cell-mediated activation of tumor-tolerized CD8 T cells publication-title: J. Immunol. doi: 10.4049/jimmunol.1201271 – volume: 16 start-page: 1170 year: 2008 ident: 10.1016/j.cellimm.2015.02.008_b0250 article-title: Enhancing the T-cell stimulatory capacity of human dendritic cells by co-electroporation with CD40L, CD70 and constitutively active TLR4 encoding mRNA publication-title: Mol. Ther. doi: 10.1038/mt.2008.77 – volume: 42 start-page: 61 year: 2005 ident: 10.1016/j.cellimm.2015.02.008_b0180 article-title: Comparable functions of plasmacytoid and monocyte-derived dendritic cells in chronic hepatitis C patients and healthy donors publication-title: J. Hepatol. doi: 10.1016/j.jhep.2004.09.014 – volume: 179 start-page: 4307 year: 2007 ident: 10.1016/j.cellimm.2015.02.008_b0130 article-title: A new class of reverse signaling costimulators belongs to the TNF family publication-title: J. Immunol. doi: 10.4049/jimmunol.179.7.4307 – volume: 49 start-page: 124 year: 2009 ident: 10.1016/j.cellimm.2015.02.008_b0075 article-title: A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma publication-title: Hepatology doi: 10.1002/hep.22626 – volume: 191 start-page: 1976 year: 2013 ident: 10.1016/j.cellimm.2015.02.008_b0245 article-title: Modulation of regulatory T cell function by monocyte-derived dendritic cells matured through electroporation with mRNA encoding CD40 ligand, constitutively active TLR4, and CD70 publication-title: J. Immunol. doi: 10.4049/jimmunol.1201008 – volume: 15 start-page: 219 year: 2008 ident: 10.1016/j.cellimm.2015.02.008_b0185 article-title: Monocyte derived dendritic cells retain their functional capacity in patients following infection with hepatitis C virus publication-title: J. Viral Hepatol. doi: 10.1111/j.1365-2893.2007.00934.x – volume: 162 start-page: 5584 year: 1999 ident: 10.1016/j.cellimm.2015.02.008_b0160 article-title: Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals publication-title: J. Immunol. doi: 10.4049/jimmunol.162.9.5584 – volume: 82 start-page: 3561 year: 2008 ident: 10.1016/j.cellimm.2015.02.008_b0220 article-title: Efficient in vitro expansion of human immunodeficiency virus (HIV)-specific T-cell responses by gag mRNA-electroporated dendritic cells from treated and untreated HIV type 1-infected individuals publication-title: J. Virol. doi: 10.1128/JVI.02080-07 – volume: 2 start-page: 533 year: 2001 ident: 10.1016/j.cellimm.2015.02.008_b0005 article-title: Global cancer statistics in the year 2000 publication-title: Lancet Oncol. doi: 10.1016/S1470-2045(01)00486-7 – volume: 163 start-page: 165 year: 2011 ident: 10.1016/j.cellimm.2015.02.008_b0070 article-title: Prolonged recurrence-free survival following OK432-stimulated dendritic cell transfer into hepatocellular carcinoma during transarterial embolization publication-title: Clin. Exp. Immunol. doi: 10.1111/j.1365-2249.2010.04246.x – volume: 9 start-page: 210 year: 2013 ident: 10.1016/j.cellimm.2015.02.008_b0055 article-title: Peptide vaccines for hepatocellular carcinoma publication-title: Hum. vaccines immunother. doi: 10.4161/hv.22473 – volume: 3 start-page: 197 year: 2006 ident: 10.1016/j.cellimm.2015.02.008_b0140 article-title: Dendritic cell as therapeutic vaccines against tumors and its role in therapy for hepatocellular carcinoma publication-title: Cell. Mol. Immunol. – volume: 95 start-page: 697 year: 2004 ident: 10.1016/j.cellimm.2015.02.008_b0030 article-title: The critical role of type-1 innate and acquired immunity in tumor immunotherapy publication-title: Cancer Sci. doi: 10.1111/j.1349-7006.2004.tb03248.x – volume: 179 start-page: 3515 year: 2007 ident: 10.1016/j.cellimm.2015.02.008_b0115 article-title: Dendritic cell expression of OX40 ligand acts as a costimulatory, not polarizing, signal for optimal Th2 priming and memory induction in vivo publication-title: J. Immunol. doi: 10.4049/jimmunol.179.6.3515 – volume: 23 start-page: 23 year: 2005 ident: 10.1016/j.cellimm.2015.02.008_b0125 article-title: TNF/TNFR family members in costimulation of T cell responses publication-title: Annu. Rev. Immunol. doi: 10.1146/annurev.immunol.23.021704.115839 – volume: 17 start-page: 5260 year: 2011 ident: 10.1016/j.cellimm.2015.02.008_b0065 article-title: Hepatocellular carcinoma-specific immunotherapy with synthesized alpha1,3-galactosyl epitope-pulsed dendritic cells and cytokine-induced killer cells publication-title: World J. Gastroenterol. doi: 10.3748/wjg.v17.i48.5260 – volume: 134 start-page: 342 year: 2014 ident: 10.1016/j.cellimm.2015.02.008_b0050 article-title: Combination of radiofrequency ablation and sequential cellular immunotherapy improves progression-free survival for patients with hepatocellular carcinoma publication-title: Int. J. Cancer doi: 10.1002/ijc.28372 – volume: 31 start-page: 323 year: 1999 ident: 10.1016/j.cellimm.2015.02.008_b0080 article-title: Dendritic cells with immature phenotype and defective function in the peripheral blood from patients with hepatocellular carcinoma publication-title: J. Hepatol. doi: 10.1016/S0168-8278(99)80231-1 – volume: 21 start-page: 1135 year: 2009 ident: 10.1016/j.cellimm.2015.02.008_b0120 article-title: A novel approach to induce human DCs from monocytes by triggering 4–1BBL reverse signaling publication-title: Int. Immunol. doi: 10.1093/intimm/dxp077 – volume: 2011 start-page: 249281 year: 2011 ident: 10.1016/j.cellimm.2015.02.008_b0145 article-title: Dendritic cell-based vaccines positively impact natural killer and regulatory T cells in hepatocellular carcinoma patients publication-title: Clin. Dev. Immunol. doi: 10.1155/2011/249281 – year: 2014 ident: 10.1016/j.cellimm.2015.02.008_b0195 article-title: Co-incubation with core proteins of HBV and HCV leads to modulation of human dendritic cells publication-title: Viral Immunol. doi: 10.1089/vim.2014.0056 – volume: 185 start-page: 698 year: 2010 ident: 10.1016/j.cellimm.2015.02.008_b0230 article-title: Intratumoral neoadjuvant immunotherapy using IL-12 and dendritic cells is an effective strategy to control recurrence of murine hepatocellular carcinoma in immunosuppressed mice publication-title: J. Immunol. doi: 10.4049/jimmunol.0900187 – volume: 97 start-page: 3171 year: 2001 ident: 10.1016/j.cellimm.2015.02.008_b0150 article-title: Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection publication-title: Blood doi: 10.1182/blood.V97.10.3171 – volume: 43 start-page: 1303 year: 2006 ident: 10.1016/j.cellimm.2015.02.008_b0010 article-title: The natural history of compensated cirrhosis due to hepatitis C virus: a 17-year cohort study of 214 patients publication-title: Hepatology doi: 10.1002/hep.21176 – volume: 8 start-page: e55264 year: 2013 ident: 10.1016/j.cellimm.2015.02.008_b0240 article-title: The two-component adjuvant IC31(R) boosts type i interferon production of human monocyte-derived dendritic cells via ligation of endosomal TLRs publication-title: PLoS ONE doi: 10.1371/journal.pone.0055264 – volume: 170 start-page: 4069 year: 2003 ident: 10.1016/j.cellimm.2015.02.008_b0100 article-title: Mature dendritic cells derived from human monocytes within 48 hours: a novel strategy for dendritic cell differentiation from blood precursors publication-title: J. Immunol. doi: 10.4049/jimmunol.170.8.4069 – volume: 56 start-page: 1931 year: 2007 ident: 10.1016/j.cellimm.2015.02.008_b0045 article-title: Spontaneous and vaccine induced AFP-specific T cell phenotypes in subjects with AFP-positive hepatocellular cancer publication-title: Cancer Immunol. Immunother. doi: 10.1007/s00262-007-0337-9 – volume: 103 start-page: 1026 year: 2004 ident: 10.1016/j.cellimm.2015.02.008_b0175 article-title: Presence of functional dendritic cells in patients chronically infected with hepatitis C virus publication-title: Blood doi: 10.1182/blood-2003-04-1339 – volume: 120 start-page: 512 year: 2001 ident: 10.1016/j.cellimm.2015.02.008_b0165 article-title: Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection publication-title: Gastroenterology doi: 10.1053/gast.2001.21212 – year: 2014 ident: 10.1016/j.cellimm.2015.02.008_b0190 article-title: Hepatitis B virus e antigen (HBeAg) may have a negative effect on dendritic cell generation publication-title: Immunobiology doi: 10.1016/j.imbio.2014.07.020 – volume: 52 start-page: 155 year: 2003 ident: 10.1016/j.cellimm.2015.02.008_b0025 article-title: A phase I study of autologous dendritic cell-based immunotherapy for patients with unresectable primary liver cancer publication-title: Cancer Immunol. Immunother. doi: 10.1007/s00262-002-0360-9 – volume: 310 start-page: 40 year: 2006 ident: 10.1016/j.cellimm.2015.02.008_b0205 article-title: In vitro methods for generating CD8+ T-cell clones for immunotherapy from the naive repertoire publication-title: J. Immunol. Methods doi: 10.1016/j.jim.2005.11.023 – volume: 27 start-page: 1023 year: 2003 ident: 10.1016/j.cellimm.2015.02.008_b0170 article-title: Additive inhibition of dendritic cell allostimulatory capacity by alcohol and hepatitis C is not restored by DC maturation and involves abnormal IL-10 and IL-2 induction publication-title: Alcohol. Clin. Exp. Res. doi: 10.1111/j.1530-0277.2003.tb04431.x – volume: 260 start-page: 56 year: 2009 ident: 10.1016/j.cellimm.2015.02.008_b0095 article-title: Fast generation of dendritic cells publication-title: Cell. Immunol. doi: 10.1016/j.cellimm.2009.09.003 – volume: 28 start-page: 824 year: 2004 ident: 10.1016/j.cellimm.2015.02.008_b0200 article-title: Acute alcohol consumption inhibits accessory cell function of monocytes and dendritic cells publication-title: Alcohol. Clin. Exp. Res. doi: 10.1097/01.ALC.0000127104.80398.9B – volume: 96 start-page: 382 year: 2014 ident: 10.1016/j.cellimm.2015.02.008_b0260 article-title: M1- and M2-macrophage polarization in rat liver cirrhosis induced by thioacetamide (TAA), focusing on Iba1 and galectin-3 publication-title: Exp. Mol. Pathol. doi: 10.1016/j.yexmp.2014.04.003 – volume: 77 start-page: 10862 year: 2003 ident: 10.1016/j.cellimm.2015.02.008_b0155 article-title: Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responses publication-title: J. Virol. doi: 10.1128/JVI.77.20.10862-10871.2003 – ident: 10.1016/j.cellimm.2015.02.008_b0225 doi: 10.1111/liv.12284 – volume: 179 start-page: 7137 year: 2007 ident: 10.1016/j.cellimm.2015.02.008_b0215 article-title: Extracellular branched-chain amino acids, especially valine, regulate maturation and function of monocyte-derived dendritic cells publication-title: J. Immunol. doi: 10.4049/jimmunol.179.10.7137 – volume: 30 start-page: 483 year: 2012 ident: 10.1016/j.cellimm.2015.02.008_b0090 article-title: Cellular immune responses to hepatocellular carcinoma: lessons for immunotherapy publication-title: Dig. Dis. doi: 10.1159/000341697 – ident: 10.1016/j.cellimm.2015.02.008_b0085 doi: 10.1016/j.clim.2011.02.014 – volume: 41 start-page: 1601 year: 2012 ident: 10.1016/j.cellimm.2015.02.008_b0020 article-title: Phase I/II study of immunotherapy using tumor antigen-pulsed dendritic cells in patients with hepatocellular carcinoma publication-title: Int. J. Oncol. doi: 10.3892/ijo.2012.1626 – volume: 480 start-page: 480 year: 2011 ident: 10.1016/j.cellimm.2015.02.008_b0035 article-title: Cancer immunotherapy comes of age publication-title: Nature doi: 10.1038/nature10673 – volume: 66 start-page: 21 year: 2012 ident: 10.1016/j.cellimm.2015.02.008_b0060 article-title: Adoptive immunotherapy for postoperative hepatocellular carcinoma: a systematic review publication-title: Int. J. Clin. Pract. doi: 10.1111/j.1742-1241.2011.02814.x – volume: 12 start-page: 2817 year: 2006 ident: 10.1016/j.cellimm.2015.02.008_b0015 article-title: A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptides publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-05-2856 – volume: 145 start-page: 1481 year: 2013 ident: 10.1016/j.cellimm.2015.02.008_b0255 article-title: Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function publication-title: Gastroenterology doi: 10.1053/j.gastro.2013.10.031 – reference: 16675576 - Clin Cancer Res. 2006 May 1;12(9):2817-25 – reference: 15992809 - J Immunol Methods. 2005 Jul;302(1-2):145-55 – reference: 11342445 - Blood. 2001 May 15;97(10):3171-6 – reference: 23442593 - Hum Vaccin Immunother. 2013 Jan;9(1):210-2 – reference: 12824825 - Alcohol Clin Exp Res. 2003 Jun;27(6):1023-31 – reference: 22171902 - Int J Clin Pract. 2012 Jan;66(1):21-7 – reference: 22798683 - J Immunol. 2012 Aug 15;189(4):1708-16 – reference: 23998316 - Liver Int. 2014 Mar;34(3):447-61 – reference: 16729298 - Hepatology. 2006 Jun;43(6):1303-10 – reference: 25150150 - Immunobiology. 2014 Dec;219(12):944-9 – reference: 12649744 - Cancer Immunol Immunother. 2003 Mar;52(3):155-61 – reference: 17878324 - J Immunol. 2007 Oct 1;179(7):4307-12 – reference: 14512536 - J Virol. 2003 Oct;77(20):10862-71 – reference: 11905707 - Lancet Oncol. 2001 Sep;2(9):533-43 – reference: 15501973 - Clin Cancer Res. 2004 Oct 15;10(20):6946-55 – reference: 23405128 - PLoS One. 2013;8(2):e55264 – reference: 10453947 - J Hepatol. 1999 Aug;31(2):323-31 – reference: 17608923 - BMC Cancer. 2007;7:119 – reference: 20498356 - J Immunol. 2010 Jul 1;185(1):698-708 – reference: 17785785 - J Immunol. 2007 Sep 15;179(6):3515-23 – reference: 17982106 - J Immunol. 2007 Nov 15;179(10):7137-46 – reference: 15166660 - Alcohol Clin Exp Res. 2004 May;28(5):824-8 – reference: 18194173 - J Viral Hepat. 2008 Mar;15(3):219-28 – reference: 16469329 - J Immunol Methods. 2006 Mar 20;310(1-2):40-52 – reference: 21969837 - Clin Dev Immunol. 2011;2011:249281 – reference: 14525790 - Blood. 2004 Feb 1;103(3):1026-9 – reference: 15771565 - Annu Rev Immunol. 2005;23:23-68 – reference: 18431362 - Mol Ther. 2008 Jun;16(6):1170-80 – reference: 21419713 - Clin Immunol. 2011 Jun;139(3):302-13 – reference: 16893500 - Cell Mol Immunol. 2006 Jun;3(3):197-203 – reference: 24747241 - Exp Mol Pathol. 2014 Jun;96(3):382-92 – reference: 9570527 - J Immunol. 1998 Feb 1;160(3):1139-47 – reference: 18234800 - J Virol. 2008 Apr;82(7):3561-73 – reference: 22971679 - Int J Oncol. 2012 Nov;41(5):1601-9 – reference: 11159892 - Gastroenterology. 2001 Feb;120(2):512-24 – reference: 23108304 - Dig Dis. 2012;30(5):483-91 – reference: 19524453 - Semin Immunol. 2009 Oct;21(5):265-72 – reference: 25148301 - Viral Immunol. 2014 Oct;27(8):412-7 – reference: 15629508 - J Hepatol. 2005 Jan;42(1):61-7 – reference: 15471553 - Cancer Sci. 2004 Sep;95(9):697-703 – reference: 24409494 - Gastroenterology. 2013 Dec;145(6):1481-4 – reference: 23842750 - J Immunol. 2013 Aug 15;191(4):1976-83 – reference: 23825037 - Int J Cancer. 2014 Jan 15;134(2):342-51 – reference: 17522860 - Cancer Immunol Immunother. 2007 Dec;56(12):1931-43 – reference: 21087443 - Clin Exp Immunol. 2011 Feb;163(2):165-77 – reference: 22219594 - World J Gastroenterol. 2011 Dec 28;17(48):5260-6 – reference: 12682236 - J Immunol. 2003 Apr 15;170(8):4069-76 – reference: 22193102 - Nature. 2011 Dec 22;480(7378):480-9 – reference: 10228041 - J Immunol. 1999 May 1;162(9):5584-91 – reference: 19684160 - Int Immunol. 2009 Oct;21(10):1135-44 – reference: 18980227 - Hepatology. 2009 Jan;49(1):124-32 – reference: 19818956 - Cell Immunol. 2009;260(1):56-62 |
SSID | ssj0011490 |
Score | 2.1191347 |
Snippet | •CD14+ monocytes from cirrhotic patients displayed enhanced M1 and M2 polarization.•MoDC derived from cirrhotic CD14+ monocytes display normal co-stimulation... Few studies have investigated the impact of liver cirrhosis on dendritic cell function. The purpose of this study was to compare the activation and... |
SourceID | pubmedcentral proquest pubmed crossref elsevier |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 36 |
SubjectTerms | Adult Aged Antigen Presentation - immunology Cell Differentiation - immunology Cell Proliferation Cells, Cultured Cirrhosis Coculture Techniques Dendritic cell Dendritic Cells - immunology Dendritic Cells - metabolism Enzyme-Linked Immunospot Assay Flow Cytometry Glypican-3 Healthy Volunteers Hepatitis C Human Humans Immunophenotyping Interferon-gamma - immunology Interferon-gamma - metabolism Lipopolysaccharide Receptors - immunology Lipopolysaccharide Receptors - metabolism Liver Cirrhosis - immunology Liver Cirrhosis - metabolism Liver Cirrhosis - pathology M1 macrophage M2 macrophage Macrophages - classification Macrophages - immunology Male Middle Aged Monocyte Monocytes - immunology Monocytes - metabolism T-Lymphocytes - immunology T-Lymphocytes - metabolism |
Title | Monocyte-derived dendritic cells from cirrhotic patients retain similar capacity for maturation/activation and antigen presentation as those from healthy subjects |
URI | https://dx.doi.org/10.1016/j.cellimm.2015.02.008 https://www.ncbi.nlm.nih.gov/pubmed/25734547 https://www.proquest.com/docview/1674689975 https://www.proquest.com/docview/1732813857 https://pubmed.ncbi.nlm.nih.gov/PMC4405471 |
Volume | 295 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqIhAXBOW1PCojcc1uHDuvY1VRLaD2RKXeLD-1qdhktcki7YUf01_amTjZsiCoxCGHTWzFmxnPfHHm-0zIx6QUBWeJi7iLXSRKl0QaEnMUa2W1sJ5phnzn84tsfim-XKVXB-R05MJgWeUQ-0NM76P1cGY2PM3ZqqqQ44szRJQMNf0BRSODXeTo5dOfuzIPgPthnQU_82PrOxbP7HqKi-PVEgnpLA3SncXf8tOf-PP3Mspf8tLZU_JkAJT0JIz5GTlw9RF5GLaY3B6RR-fDx_Pn5Abmb2O2nYssuN0PZynEHNtvdUBxiC1Frgk11Xq9aPDkoLnaUqxJrGraVssKXoSpgQRrAL1TALx0icqgvXlnyJEIK7xU1RaODqU-6eqO4QQXWtotmtaFewUW5pa2G43rQe0Lcnn26dvpPBq2aIgMPPUuygxnNjbCG5spH3MF-b5UiTdZZjMAL5Y7rZMchex4AvnYIKJguQZgF2vrPX9JDuumdq8JTWNllS-YSpgTvMh1qY1ODNPK5d56PSFiNIw0g345bqPxXY6FatdysKdEe8o4kWDPCZnuuq2CgMd9HYrR6nLPEyUkmfu6fhi9RMIsxRaqds2mlcj1yODVNk__0QZ1kxgv0nxCXgXP2o0YAitH6bUJyfd8btcAVcL3r9TVolcLFwDJAYG8-f-_9ZY8xl-hzPMdOezWG_ceoFinj_u5dkwenHz-Or-4BW4pOzo |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6VIigXBAVKeC4SVyde7_p1RFWrAE1PrdTbal9WXBE7ih2kXPgx_FJmvHZKqKASh1y8u8ra8_q8nvmGkI9RLjLOIhdwF7pA5C4KNATmINTKamELphnWO8_Ok-ml-HIVX-2R46EWBtMqe9_vfXrnrfsrk_5pTpZliTW-aCEiZ8jpDyj6HrkvwHyxjcH4xzbPA_C-P2jB7_w4_aaMZ3I9xtPxcoEV6Sz23J3Z3wLUbQD6Zx7lb4Hp9Al53CNK-slv-inZc9UheeB7TG4OycNZ__X8GfkJBlybTesCC3r33VkKTsd2vQ4obrGhWGxCTblazWu82JOuNhSTEsuKNuWihDdhaiDCGoDvFBAvXSA1aCffCRZJ-CNeqioLvxa5PunypsQJBhrazuvG-f_yZZgb2qw1Hgg1z8nl6cnF8TToezQEBh57GySGMxsaURibqCLkCgJ-rqLCJIlNAL1Y7rSOUmSy4xEEZIOQgqUakF2obVHwF2S_qiv3ktA4VFYVGVMRc4Jnqc610ZFhWrm0sIUeETEIRpqewBz7aHyTQ6batezlKVGeMowkyHNExttlS8_gcdeCbJC63FFFCVHmrqUfBi2RYKY4Q1WuXjcSiz0SeLdN43_MQeIkxrM4HZEjr1nbHYNn5ci9NiLpjs5tJyBN-O5IVc47unABmBwgyKv_v6335GB6MTuTZ5_Pv74mj3DE53y-Ifvtau3eAi5r9bvO7n4BQ4s8yA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Monocyte-derived+dendritic+cells+from+cirrhotic+patients+retain+similar+capacity+for+maturation%2Factivation+and+antigen+presentation+as+those+from+healthy+subjects&rft.jtitle=Cellular+immunology&rft.au=Tanoue%2C+Shiroh&rft.au=Chang%2C+Li-Yuan&rft.au=Li%2C+Yonghai&rft.au=Kaplan%2C+David+E&rft.date=2015-05-01&rft.issn=0008-8749&rft.volume=295&rft.issue=1&rft.spage=36&rft.epage=45&rft_id=info:doi/10.1016%2Fj.cellimm.2015.02.008&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0008-8749&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0008-8749&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0008-8749&client=summon |